Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer

Clinical trial NCT03798639 · COMPLETED

Trial details

NCT number: NCT03798639
Sponsor: Claire Verschraegen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Merkel Cell Carcinoma Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8 Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8

Start date: 2019-01-07
Primary completion: 2022-12-02
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.